玖玖资源网站,爆乳久久久,日韩精品乱码久久久蜜桃,精品呦国产一区二区三区,国产伦高清一区二区三区,sese一区二区,午夜精品福利一区二区三区,三级黄色网站久久免费

首頁
訂購/客服:400-666-5481

BIBX 1382

    
99.1%

BIBX 1382

源葉(MedMol)
S80514 一鍵復制產品信息
196612-93-8
C18H19ClFN7
387.8418
貨號 規格 價格 上海 北京 武漢 南京 購買數量
S80514-5mg
99.1% ¥400.00 6 - - -
S80514-10mg
99.1% ¥690.00 7 - - -
S80514-25mg
99.1% ¥1180.00 6 - - -
產品介紹 參考文獻 質檢證書(COA) 摩爾濃度計算器 相關產品

產品介紹

Falnidamol (BIBX 1382) is an orally active, selective EGFR tyrosine kinase inhibitor with an IC50 of 3 nM. Falnidamol displays > 1000-fold lower potency against ErbB2 (IC50=3.4 μM) and a range of other related tyrosine kinases (IC50>10 μM). Falnidamol is a pyrimido-pyrimidine compound and has anti-cancer activity

產品描述: Falnidamol (BIBX 1382) is an orally active, selective EGFR tyrosine kinase inhibitor with an IC50 of 3 nM. Falnidamol displays > 1000-fold lower potency against ErbB2 (IC50=3.4 μM) and a range of other related tyrosine kinases (IC50>10 μM). Falnidamol is a pyrimido-pyrimidine compound and has anti-cancer activity
靶點: EGFR:3 nM (IC50);ErbB2:3.4 μM (IC50);EGFR
體外研究: Falnidamol (BIBX 1382) demonstrates antiproliferative activity in mitogenic assays performed with KB cells
體內研究: Falnidamol (BIBX 1382; p.o.; 10 mg/kg/day; 16 days) completely suppressed tumor growth of human A431 xenografts with respective a T/C value of 15% after 2 weeks of treatment. Falnidamol (50 mg/kg/day for 2 weeks) results in dephosphorylation of the EGF receptor in A431 xenograft-bearing mice. With Falnidamol (p.o.; 10 mg/kg/day; 16 days), the C4h is 2222 nM and the C24h is 244 nM. Animal Model: Five- to six-week-old athymic NMRI-nu/nu female mice (21-31 g) with A431, FaDu, or HN5 cells Dosage: 10 mg/kg Administration: p.o.; daily; 16 days Result: Completely suppressed tumor growth of human A431 xenografts with respective T/C values of 15 and 6% after 2 weeks of treatment. Animal Model: Five- to six-week-old athymic NMRI-nu/nu female mice (21–31 g) with A431 cells Dosage: 10 mg/kg (Pharmacokinetic Analysis) Administration: p.o.; daily; 16 days Result: The C4h is 2222 nM and the C24h is 244 nM.
參考文獻: 1. Dittrich Ch, et al. Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration. Eur J Cancer. 2002 May;38(8):1072-80. 2. Solca FF, et al. Inhibition of epidermal growth factor receptor activity by two pyrimidopyrimidine derivatives. J Pharmacol Exp Ther. 2004 Nov;311(2):502-9.
溶解性: soluble  in  DMSO
保存條件: -20℃
配置溶液濃度參考:
1mg 5mg 10mg
1 mM 2.578 ml 12.892 ml 25.784 ml
5 mM 0.516 ml 2.578 ml 5.157 ml
10 mM 0.258 ml 1.289 ml 2.578 ml
50 mM 0.052 ml 0.258 ml 0.516 ml
注意: 部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。

參考文獻

質檢證書(COA)

如何獲取質檢證書(COA)?
請輸入貨號和一個與之匹配的批號。
例如:
批號:JS298415 貨號:S20001-25g
在貨品標簽上如何找到貨號和批號?

摩爾濃度計算器

質量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

=
×
×
主站蜘蛛池模板: 浦县| 阳高县| 水城县| 和平区| 博客| 乌鲁木齐市| 夏津县| 略阳县| 拜泉县| 左权县| 威宁| 武鸣县| 诸城市| 芦山县| 弥勒县| 南乐县| 衡阳市| 黄浦区| 丰镇市| 若尔盖县| 玉溪市| 启东市| 大宁县| 砚山县| 兴和县| 朔州市| 琼海市| 杭州市| 荥经县| 五莲县| 息烽县| 汾西县| 崇文区| 邹城市| 明水县| 清徐县| 西城区| 礼泉县| 扬州市| 青海省| 杨浦区|